While its expression and actions can vary depending on the specific disease model and stage, evidence suggests that modulating renalase activity or expression may hold therapeutic potential for conditions like atherosclerosis and heart failure, particularly by influencing inflammation, fibrosis, and key signalling pathways. Here, RNLS is linked to atherosclerosis.